Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
Recruiting
N/A
Interventional Study
ST-segment Elevation Myocardial Infarction (STEMI)
Left Ventricular Thrombus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 320 (estimated)
- Sponsor
- Jilin University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Contemporary data are lacking regarding the management of left ventricular thrombus (LVT) developed after ST segment elevation myocardial infarction
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Established ST segment elevation myocardial infarction within 7 days Left ventricular thrombus (LVT) is detected by either cardiac magnetic resonance (CMR) or TTE.
Ongoing treatment with dual anti-platelet therapy according to ESC/AHA guidelines at the time of randomization
Ex…